1. Molecular and immune targets for Merkel cell carcinoma therapy and prevention
   Leah Cohen et al, 2019, Molecular Carcinogenesis CrossRef
2. Role and Therapeutic Targeting of the PI3K/Akt/mTOR Signaling Pathway in Skin Cancer: A Review of Current Status and Future Trends on Natural and Synthetic Agents Therapy
   Jean Chamcheu et al, 2019, Cells CrossRef
3. Merkel Cell Polyomavirus and Human Merkel Cell Carcinoma
   Wei Liu et al, 2021, Viruses and Human Cancer CrossRef
4. Therapeutic Potential of 5′-Methylschweinfurthin G in Merkel Cell Polyomavirus-Positive Merkel Cell Carcinoma
   Emily J. Koubek et al, 2022, Viruses CrossRef
5. The biology and treatment of Merkel cell carcinoma: current understanding and research priorities
   null null et al, 2018, Nature Reviews Clinical Oncology CrossRef
6. Bloom Syndrome Protein Activates AKT and PRAS40 in Prostate Cancer Cells
   Kun Chen et al, 2019, Oxidative Medicine and Cellular Longevity CrossRef
7. Virus-positive Merkel Cell Carcinoma Is an Independent Prognostic Group with Distinct Predictive Biomarkers
   Kelly L. Harms et al, 2021, Clinical Cancer Research CrossRef
8. Acquired resistance to PI3K/mTOR inhibition is associated with mitochondrial DNA mutation and glycolysis
   King Xin Koh et al, 2017, Oncotarget CrossRef
9. Pharmacological Inhibition of Serine Palmitoyl Transferase and Sphingosine Kinase-1/-2 Inhibits Merkel Cell Carcinoma Cell Proliferation
   Vishwanath Kumble Bhat et al, 2019, Journal of Investigative Dermatology CrossRef